$UTHR News

UTHR or SDZNY: Which Is the Better Value Stock Right Now?

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Published in The Lancet

United Therapeutics Announces Publication of ADVANCE OUTCOMES Study in The Lancet; Ralinepag Remains Investigational for PAH

United Therapeutics CEO Sells $5 Million of Shares. What Does This Mean for Investors?

JP Morgan Maintains Overweight on United Therapeutics, Raises Price Target to $687

United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors

United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Q2 Release

United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026

United Therapeutics (UTHR) Stock Looks Cheap On Fair Value Despite Strong Returns

United Therapeutics (UTHR) Following FDA Approval Is The Stock Fully Valued

B of A Securities Maintains Neutral on United Therapeutics, Lowers Price Target to $613

United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know

Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation?

RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $704

United Therapeutics: Trifecta Of 2026 Tyvaso Franchise Filings Makes It A Compelling Buy

UTHR Strengthens Regenerative Medicine Platform With Thymmune Deal

United Therapeutics Corporation Acquires Thymmune Therapeutics

United Therapeutics Expands Immune Therapy Pipeline With Thymmune

United Therapeutics Acquired Thymmune Therapeutics For $140M In Cash

The Oliver Patch Project Announces United Therapeutics Corporation Named Visionary/Presenting Sponsor of National Patch Day 2026